Literature DB >> 34301776

Radionuclide Imaging of the Gut-Brain Axis in Parkinson Disease.

Jacob Horsager1, Karoline Knudsen1, Per Borghammer2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34301776      PMCID： PMC8612321          DOI： 10.2967/jnumed.121.262300

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  11 in total

1.  Objective Colonic Dysfunction is Far more Prevalent than Subjective Constipation in Parkinson's Disease: A Colon Transit and Volume Study.

Authors:  Karoline Knudsen; Tatyana D Fedorova; Anne C Bekker; Peter Iversen; Karen Østergaard; Klaus Krogh; Per Borghammer
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

2.  Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.

Authors:  Tatyana D Fedorova; Louise B Seidelin; Karoline Knudsen; Anna C Schacht; Jacob Geday; Nicola Pavese; David J Brooks; Per Borghammer
Journal:  Neurology       Date:  2017-01-18       Impact factor: 9.910

3.  In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.

Authors:  Trine Gjerløff; Steen Jakobsen; Adjmal Nahimi; Ole L Munk; Dirk Bender; Aage K O Alstrup; Karina H Vase; Søren B Hansen; David J Brooks; Per Borghammer
Journal:  J Nucl Med       Date:  2014-10-16       Impact factor: 10.057

4.  Objective intestinal function in patients with idiopathic REM sleep behavior disorder.

Authors:  Karoline Knudsen; Tatyana D Fedorova; Allan K Hansen; Michael Sommerauer; Anne-Mette Haase; Kristina B Svendsen; Marit Otto; Karen Østergaard; Klaus Krogh; Per Borghammer
Journal:  Parkinsonism Relat Disord       Date:  2018-08-18       Impact factor: 4.891

5.  Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.

Authors:  Jacob Horsager; Katrine B Andersen; Karoline Knudsen; Casper Skjærbæk; Tatyana D Fedorova; Niels Okkels; Eva Schaeffer; Sarah K Bonkat; Jacob Geday; Marit Otto; Michael Sommerauer; Erik H Danielsen; Einar Bech; Jonas Kraft; Ole L Munk; Sandra D Hansen; Nicola Pavese; Robert Göder; David J Brooks; Daniela Berg; Per Borghammer
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

6.  Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.

Authors:  Trine Gjerløff; Tatyana Fedorova; Karoline Knudsen; Ole L Munk; Adjmal Nahimi; Steen Jacobsen; Erik H Danielsen; Astrid J Terkelsen; John Hansen; Nicola Pavese; David J Brooks; Per Borghammer
Journal:  Brain       Date:  2014-12-23       Impact factor: 13.501

7.  In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients.

Authors:  Tatyana Dmitrievna Fedorova; Karoline Knudsen; Bolette Hartmann; Jens J Holst; Frank Viborg Mortensen; Klaus Krogh; Per Borghammer
Journal:  Neurogastroenterol Motil       Date:  2019-11-12       Impact factor: 3.598

Review 8.  Gastric emptying in Parkinson's disease - A mini-review.

Authors:  Karoline Knudsen; Martha Szwebs; Allan K Hansen; Per Borghammer
Journal:  Parkinsonism Relat Disord       Date:  2018-06-06       Impact factor: 4.891

9.  In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.

Authors:  Karoline Knudsen; Tatyana D Fedorova; Allan K Hansen; Michael Sommerauer; Marit Otto; Kristina B Svendsen; Adjmal Nahimi; Morten G Stokholm; Nicola Pavese; Christoph P Beier; David J Brooks; Per Borghammer
Journal:  Lancet Neurol       Date:  2018-06-01       Impact factor: 44.182

10.  A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice.

Authors:  Collin Challis; Neha Jain; Timothy R Sampson; Anastasiya Moiseyenko; Mark S Ladinsky; Gauri G Shastri; Taren Thron; Brittany D Needham; Istvan Horvath; Justine W Debelius; Stefan Janssen; Rob Knight; Pernilla Wittung-Stafshede; Viviana Gradinaru; Matthew Chapman; Sarkis K Mazmanian
Journal:  Elife       Date:  2020-02-11       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.